CobraZol Roll-on Topical Gel

Manufacturer
Nature's Innovation, Inc.
Effective date
2021-01-14
Label type
HUMAN OTC DRUG LABEL
Version
3
Source
legacy-cache
Hydrated at
2026-08-01 22:56:25

Label at a glance#

ProductCobraZol
Active ingredientARNICA MONTANA, CAPSICUM, CROTALUS HORRIDUS HORRIDUS VENOM, LACHESIS MUTA VENOM, NAJA NAJA VENOM
Label structure10 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients

Arnica montana (Moutain arnica) 1X HPUS

Capsicum annum (Cayenne pepper) 2X HPUS

Crotalus horridus (Rattlesnake venom) 6X HPUS

Lachesis muta (Bushmaster venom) 8X HPUS

Naja tripudians (Indian Cobra venom) 5X HPUS

The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States.

OTC - PURPOSE SECTION

Purpose

Nerve Injury, Spasms and Muscular Pain

Aching Muscle Symptom Relief

Analgesic

Analgesic

Analgesic

INDICATIONS & USAGE SECTION

UsesSymptomatic relief of muscle, joint neuralgia and arthritis pain and stiffness.

WARNINGS SECTION

Warnings

For External Use Only.

OTC - STOP USE SECTION

  • If symptoms persist or worsen, discontinue use and seek medical attention.

OTHER SAFETY INFORMATION

  • This product contains Capsicum, avoid contact with eyes.  If product gets into eyes, flushy with water.  Seek medical attention.

OTC - DO NOT USE SECTION

  • Do not use on open wounds.

OTC - PREGNANCY OR BREAST FEEDING SECTION

  • Pregnant or nursing women and children should not use this product unless advised by a physician.

OTC - ASK DOCTOR SECTION

  • If swallowed, get medical help or contact a Poison Control Center right away.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

  • Keep out of the reach of children.

DOSAGE & ADMINISTRATION SECTION

Directions

  • Roll gel directly onto affected area.
  • Rub thoroughly into area with pain.
  • Wash hands immediately to prevent numbing effect and contact with capsicum in eyes.
  • Use 3-4 times per day for 1st week.  Use as needed thereafter to relieve discomfort.
  • Allow several days for maximum effect.

OTHER SAFETY INFORMATION

Other Information

  • Do not use if safety band is broken.
  • Intended for use in cases of recurring pain.
  • This product is NOT intended to treat disease.  It assists in providing temporary relief.
  • This product is for temporary relief of mild to moderate chronic pain.

INACTIVE INGREDIENT SECTION

Inactive Ingredients

Benzalkonium Chloride, Boswellia Serrata Resin Extract (Indian Franckincense), Curcuma Longa Root Extract (Curcumin), Glucono Delta Lactone, Isopropyl Alcohol, Menthyl Lactate, Methylcellulose, MSM (Methylsulfonylmethane), Oleic Acid, Propylene Glycol, Purified Water

OTC - QUESTIONS SECTION

Questions?  Call 866-371-2499

www.cobrazol.xom

Manufactured by: Nature's Innovation, Inc.

5317 Palmero Ct., Buford, GA 30518

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

for Chronic Pain Relief

CobraZol

Roll-on Topical Gel

HOMEOPATHIC

  • Scent Free
  • Analgesic*
  • Anti-inflammatory*
  • Neuralgia*
  • Arthritis Pain*
  • Muscle & Joint Pain*

Patent Pending

Net Wt. 3.0 oz. (88.721 mL)

LabelLabel

CartonCarton

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
10893-900COBRAZOL (ARNICA MONTANA, CAPSICUM ANNUM, CROTALUS HORRIDUS, LACHESIS MUTA, NAJA TRIPUDIANS) GEL [NATURE'S INNOVATION, INC.]3Legacy NDC20210115_37fb2575-8af0-4a50-b406-faae5b824bc4.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
ARNICA MONTANAACTIVE INGREDIENTO80TY208ZW1
CAPSICUMACTIVE INGREDIENT00UK7646FG1
CROTALUS HORRIDUS HORRIDUS VENOMACTIVE INGREDIENTYHA2XLJ9561
LACHESIS MUTA VENOMACTIVE INGREDIENTVSW71SS07I1
NAJA NAJA VENOMACTIVE INGREDIENTZZ4AG7L7VM1
ARNICA MONTANAACTIVE MOIETYO80TY208ZW1
CAPSICUMACTIVE MOIETY00UK7646FG1
CROTALUS HORRIDUS HORRIDUS VENOMACTIVE MOIETYYHA2XLJ9561
LACHESIS MUTA VENOMACTIVE MOIETYVSW71SS07I1
NAJA NAJA VENOMACTIVE MOIETYZZ4AG7L7VM1
BENZALKONIUM CHLORIDEINACTIVE INGREDIENTF5UM2KM3W71
DIMETHYL SULFONEINACTIVE INGREDIENT9H4PO4Z4FT1
GLUCONOLACTONEINACTIVE INGREDIENTWQ29KQ9POT1
INDIAN FRANKINCENSEINACTIVE INGREDIENT4PW41QCO2M1
ISOPROPYL ALCOHOLINACTIVE INGREDIENTND2M4163021
METHYL LACTATE, L-INACTIVE INGREDIENT0379G9C44S1
METHYLCELLULOSE (1500 CPS)INACTIVE INGREDIENTP0NTE483641
OLEIC ACIDINACTIVE INGREDIENT2UMI9U37CP1
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V31
TURMERICINACTIVE INGREDIENT856YO1Z64F1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 18 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
10893-90010893-900-03

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 16 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 3 · 132 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS63.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302GEL / TOPICAL75 mgExact identifier — unii candidate
9 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SYRUP / ORAL5700 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7GEL / OPHTHALMIC0.01 %w/wExact identifier — unii candidate
24 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / AURICULAR (OTIC)0.02 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / TOPICAL5.28 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED, EXTENDED RELEASE / ORAL19 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION/ DROPS / TOPICALNAExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / ORAL22602 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / OPHTHALMIC1 mgExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3EMULSION / TOPICAL8 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPCAPSULE / ORAL8759 mgExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, EXTENDED RELEASE / ORAL9 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SPRAY, METERED / NASAL240 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / AURICULAR (OTIC)0 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7LIQUID / NASAL0.2 mg/1mlExact identifier — unii candidate
24 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPCREAM / TOPICAL25 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / DENTAL2 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAVENOUS4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, DELAYED RELEASE / ORAL36 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / TOPICAL0.02 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPSOLUTION / TOPICAL7.4 %w/wExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM, EXTENDED RELEASE / TRANSDERMAL58.13 mgExact identifier — unii candidate
81 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPSYSTEM / TRANSDERMAL22 mgExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT, AUGMENTED / TOPICAL714 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAMUSCULAR4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAVENOUS16624 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302SWAB / TOPICAL43.9 %w/wExact identifier — unii candidate
9 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION/ DROPS / OPHTHALMIC0.75 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
METHYLCELLULOSE (1500 CPS)METHYLCELLULOSE (1500 MPA.S)P0NTE48364TABLET / ORAL319 mgExact identifier — unii candidate
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION, CONCENTRATE / INTRAVENOUS50.33 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / OPHTHALMIC1 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPGEL, METERED / TOPICAL88 mgExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TRANSDERMAL500 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION/ DROPS / TOPICAL0.01 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, COATED / ORAL16 mgExact identifier — unii candidate
81 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPINJECTION, EMULSION / INTRAVENOUS0.03 %w/vExact identifier — unii candidate
11 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET / ORAL64 mgExact identifier — unii candidate
81 equally ranked IID candidates
ISOPROPYL ALCOHOLISOPROPYL ALCOHOLND2M416302TABLET, EXTENDED RELEASE / ORALNAExact identifier — unii candidate
9 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3DROPS / ORAL200 mg/1mlExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / TOPICAL5148 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CLOTH / TOPICAL0.03 mg/mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3TABLET, FILM COATED / ORAL96 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SUSPENSION / AURICULAR (OTIC)0.01 %w/vExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
OLEIC ACIDOLEIC ACID2UMI9U37CPFILM, EXTENDED RELEASE / TRANSDERMAL10 mgExact identifier — unii candidate
11 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SOLUTION / NASAL40.46 mg/100mlExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3FILM / BUCCAL1.48 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7INJECTION / INTRAMUSCULAR1 mgExact identifier — unii candidate
24 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CONCENTRATE / ORAL7000 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / OPHTHALMIC0.44 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SUSPENSION / RECTAL90400 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION/ DROPS / AURICULAR (OTIC)ADJ PHExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3LOTION / TOPICAL3392 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION / INTRAMUSCULAR7459 mgExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / TOPICAL4886 mgExact identifier — unii candidate
81 equally ranked IID candidates
BENZALKONIUM CHLORIDEBENZALKONIUM CHLORIDEF5UM2KM3W7SHAMPOO / TOPICAL0.2 %w/wExact identifier — unii candidate
24 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
963c5e8e-3744-4ca0-bcc0-43357d34432a37fb2575-8af0-4a50-b406-faae5b824bc42025-07-25WarningsExact identifier
spl set id: 37fb2575-8af0-4a50-b406-faae5b824bc4

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.